Add-on aliskiren treatment can decrease blood pressure but requires attention to risks of renal impairment and hyperkalemia Chikushi Anti-Hypertension Trial-Rasilez® (CHAT-Ras)
Okamura, Keisuke, Takamiya, Yosuke, Mori, Ken, Shirai, Kazuyuki, Urata, HidenoriJournal:
Clinical and Experimental Hypertension
DOI:
10.1080/10641963.2020.1723618
Date:
February, 2020
File:
PDF, 1.42 MB
2020